Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels - The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group,null. (N Engl J Med, 1998)